Envista Holdings Corp
General ticker "NVST" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.5B
Envista Holdings Corp does not follow the US Stock Market performance with the rate: -9.9%.
Estimated limits based on current volatility of 2.1%: low 18.16$, high 18.93$
Factors to consider:
- North America accounted for 51.1% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [16.30$, 28.56$]
- 2024-12-30 to 2025-12-30 estimated range: [16.90$, 28.91$]
Financial Metrics affecting the NVST estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.53
- Positive: 1.03 < Operating profit margin, % of 1.23
- Negative: negative Net income
- Positive: 2.35 < Operating cash flow per share per price, % of 6.97
- Positive: Interest expense per share, $ of 0.38 <= 0.74
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
Short-term NVST quotes
Long-term NVST plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2,508.90MM | $2,569.10MM | $2,566.50MM |
| Operating Expenses | $2,202.70MM | $2,249.90MM | $2,535.00MM |
| Operating Income | $306.20MM | $319.20MM | $31.50MM |
| Non-Operating Income | $-51.70MM | $-35.30MM | $-86.40MM |
| Interest Expense | $54.10MM | $38.40MM | $63.40MM |
| R&D Expense | $100.50MM | $100.10MM | $93.80MM |
| Income(Loss) | $254.50MM | $283.90MM | $-54.90MM |
| Taxes | $-9.00MM | $45.90MM | $45.30MM |
| Other Income(Loss) | $77.00MM | $5.10MM | $0.00MM |
| Profit(Loss) | $340.50MM | $243.10MM | $-100.20MM |
| Stockholders Equity | $4,057.60MM | $4,206.90MM | $4,173.90MM |
| Inventory | $263.80MM | $300.80MM | $258.80MM |
| Assets | $6,574.20MM | $6,587.00MM | $6,605.10MM |
| Operating Cash Flow | $391.40MM | $182.70MM | $275.70MM |
| Capital expenditure | $54.70MM | $75.70MM | $58.20MM |
| Investing Cash Flow | $232.90MM | $-657.30MM | $-62.40MM |
| Financing Cash Flow | $-465.60MM | $12.50MM | $118.90MM |
| Earnings Per Share* | $1.63 | $1.46 | $-0.60 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.